PatternsRadar
Sign in

AGARWALEYEDr. Agarwal's Health Care Limited

NSE
553.40INR+0.30 (+0.05%)Close · 20 Nov 2026
5 Nov 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹17,545 CrMarket cap
101.2P/E (TTM)
51.8%Delivery

Filings & corporate actions

8 results filed
CSV
Next results · Q3 FY27
Expected 30 Jan 2027 – 28 Feb 2027
Estimate: filed 30–59 days after quarter end, last 8 times
2026
  • 5 NovresultsResults · Q2 FY27 · consolidated and standalone+0.9%NSE
  • 9 OctshareholdingShareholding · 30 Sept 2026+1.4%NSE
  • 4 AugresultsResults · Q1 FY27 · consolidated and standalone+5.6%NSE
  • 7 JulshareholdingShareholding · 30 Jun 2026-1.8%NSE
  • 21 MayresultsResults · Q4 FY26 · consolidated and standalone-0.4%NSE
  • 13 AprshareholdingShareholding · 31 Mar 2026-0.6%NSE
  • 3 FebresultsResults · Q3 FY26 · consolidated and standalone+1.0%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-1.7%NSE

Reaction to results · all yearsrose on day 0 in 4 of 8 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY275 Nov 2026+0.9%+7.6%—1.0×
Q1 FY274 Aug 2026+5.6%+3.6%+4.2%6.8×
Q4 FY2621 May 2026-0.4%+0.1%-1.8%2.5×
Q3 FY263 Feb 2026+1.0%+2.7%-0.2%0.6×
Q2 FY2630 Oct 2025-2.4%-3.0%+2.8%1.5×
Q1 FY2612 Aug 2025+0.4%+1.3%-3.6%1.0×
Q4 FY2529 May 2025-1.6%+0.5%+13.3%1.5×
Q3 FY2515 Feb 2025-3.3%-8.3%-4.9%—
Average+0.0%+0.6%+1.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+31.4%
Profit YoY+84.4%
Interest cost YoY-11.0%
Revenue QoQ+6.7%
Profit QoQ+21.0%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open549.60
Day range547.55 – 557.90
52-week range401.00 – 571.90
From 52w high-3.2%
RSI (14)69.3
ATR (14)17.78
Volume86.1K
Avg volume (20D)2.45L
Rel volume0.35×
Volatility (1Y)25.9%
Turnover₹4.8Cr
Traded value (NSE)₹4.8Cr
VWAP554.31
SMA 50 / 200501.53 / 474.56
Price band20%

Delivery percentage

Latest · 20 Nov 202651.8%
20-day avg51.7%
1-year avg50.7%
Percentile (own history)59th
Range8.1–95.3%
Sessions444

Over the last 20 sessions AGARWALEYE settled 51.7% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 50.7%. The latest session ranks higher than 59% of the 444 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders42.1K · -1.0% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy100 days ago

Performance returns

1D1W1M3M6M1Y
Price+0.05%+0.47%+18.11%+10.00%+15.03%+5.71%

Valuation

Market cap₹17,545 Cr
Market cap (NSE)₹17,544 Cr
Free-float cap₹11,873 Cr
P/E (TTM)101.2
P/E (NSE)85.4
EPS (TTM)5.47
P/B7.8
Net margin (TTM)7.3%
Other income / PBT13.3%
ROE8.3%
Debt / equity0.09
Shares outstanding31.70Cr
Listed4 Feb 2025

Ownership

Promoter32.33%
Promoter Δ QoQ-0.01 pp
Public67.67%
FII49.56%
DII15.87%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)529.9564.1614.0655.5
YoY chg+23.0%+22.6%+26.0%+31.4%
Net profit (₹ Cr)43.650.055.056.9
YoY chg+54.5%+17.4%+44.6%+55.8%
Net margin8.2%8.9%9.0%8.7%
EPS1.061.241.421.64

Shareholding over time

By quarter

30 Sept 2026 · promoter 32.33% · public 67.67%
3 Feb 2025: promoter 32.45%31 Mar 2025: promoter 32.45%30 Jun 2025: promoter 32.42%30 Sept 2025: promoter 32.42%31 Dec 2025: promoter 32.39%31 Mar 2026: promoter 32.36%30 Jun 2026: promoter 32.34%30 Sept 2026: promoter 32.33%
2025-022026-09
  • Promoter
  • Public and others
Promoter
32.33%
Public
67.67%
Promoter change
-0.01 pp
Filed
9 Oct 2026
FII
49.56%
DII
15.87%
Promoter pledged
0.00%

Who the public is

Mutual funds
14.18%

+8.16 pp QoQ

Insurance
1.06%

0.00 pp QoQ

FPI
19.05%

+4.23 pp QoQ

Retail ≤ ₹2L
1.67%

+0.01 pp QoQ

HNI > ₹2L
0.15%

0.00 pp QoQ

NRI
0.05%

+0.01 pp QoQ

Bodies corporate
0.31%

+0.25 pp QoQ

Shareholders
42,055

-1.0% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
HYPERION INVESTMENTS PTE. LTD.Foreign15.47%
ARVON INVESTMENTS PTE.LTD.Foreign9.87%
GOVERNMENT OF SINGAPOREFPI6.16%
INVESCO INDIA FLEXI CAP FUNDMutual fund5.52%
CLAYMORE INVESTMENTS (MAURITIUS) PTE. LTDForeign5.17%
ICICI PRUDENTIAL HEALTHCARE FUNDMutual fund5.06%
ATHIYA AGARWALPromoter · Individual4.45%
AMAR AGARWALPromoter · Individual4.45%
ASHAR AGARWALPromoter · Individual4.45%
ASHVIN AGARWALPromoter · Individual4.45%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Bulk & block deals · 12 Aug 2026

CSV
12 of 15 deals
By year
DateDealClientQuantityPriceValue
12 Aug 2026Sell · bulkHYPERION INVESTMENTS PTE. LTD.2.42Cr501.03₹1,210.5Cr
12 Aug 2026Sell · bulkCLAYMORE INVESTMENTS (MAURITIUS) PTE.LTD.1.59Cr501.54₹797.4Cr
12 Aug 2026Buy · bulkICICI PRUDENTIAL MUTUAL FUND62.12L501.00₹311.2Cr
12 Aug 2026Buy · bulkPOLAR CAPITAL FUNDS PLC-HEALTHCARE OPPORTUNITIES FUND36.26L501.00₹181.7Cr
12 Aug 2026Buy · bulkINVESCO MUTUAL FUND35.65L504.64₹179.9Cr
12 Aug 2026Buy · bulkMARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED19.60L502.46₹98.5Cr
12 Aug 2026Buy · bulkALLIANZ GLOBAL INVESTORS GMBH ACTING ON BEHALF OF ALLIANZ EEE FONDS17.72L501.00₹88.8Cr
12 Aug 2026Sell · bulkMARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED6.51L510.96₹33.3Cr
2 Sept 2025Sell · block, also bulkGOLDMAN SACHS (SINGAPORE) PTE - ODI16.54L433.25₹71.6Cr
2 Sept 2025Buy · blockGOLDMAN SACHS BANK EUROPE SE- ODI16.54L433.25₹71.6Cr
2 Sept 2025Buy · bulkGOLDMAN SACHS BANK EUROPE SE - ODI16.54L433.25₹71.6Cr
29 Aug 2025Sell · blockGOLDMAN SACHS (SINGAPORE) PTE - ODI4.29L439.10₹18.8Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 5 Feb 2025 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations430.7460.2487.4498.7529.9564.1614.0655.5
Other income12.715.413.47.910.512.66.49.8
Total income443.4475.7500.8506.6540.4576.7620.4665.2
Total expenses402.4414.6447.2453.0475.6501.4545.3585.3
└ Finance costs28.425.024.722.621.122.123.423.0
└ Depreciation58.260.463.067.968.876.778.382.7
Profit before tax41.058.553.653.764.876.675.179.9
Tax expense12.816.015.517.221.126.720.123.0
Net profit28.242.638.136.543.650.055.056.9
EPS0.731.040.950.941.071.251.431.65
Net margin6.56%9.25%7.81%7.32%8.23%8.86%8.96%8.67%
PBT margin9.52%12.72%11.00%10.76%12.22%13.58%12.24%12.19%
Tax rate31.11%27.29%28.99%32.00%32.63%34.80%26.78%28.84%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 5 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY25H1 FY26FY26H1 FY27
Total assets3,671.63,786.13,941.84,207.2
Current assets794.1655.9573.0522.6
└ Cash & equivalents103.697.790.6100.5
└ Other bank balances154.591.538.70.2
└ Current investments263.7207.5152.370.7
└ Trade receivables123.6138.2160.9187.0
└ Inventories80.378.494.0108.4
Total equity1,926.82,018.72,119.72,236.1
└ Attributable to owners1,866.61,930.82,025.52,237.4
└ Non-controlling interest60.287.994.2(1.3)
└ Share capital31.631.631.731.7
Borrowings246.9179.8157.3200.6
└ Current89.634.524.044.9
└ Non-current157.3145.3133.3155.8
Trade payables153.1163.4149.3172.0
Current liabilities477.8459.4461.5508.1
Total liabilities1,744.81,767.41,822.11,971.1
Net debt(275.0)(216.9)(124.3)29.2
Debt / equity0.130.090.070.09
Current ratio1.661.431.241.03

Cash flow, year to date

 FY25H1 FY26FY26H1 FY27
Operating cash flow360.3262.2519.0280.5
└ Capex(320.9)(219.7)(460.6)(279.4)
Free cash flow39.442.458.41.0
Investing cash flow(750.3)(136.1)(308.5)(233.5)
Financing cash flow381.9(131.9)(220.4)(36.9)
└ Dividends paid(0.8)(0.1)(1.1)(0.4)
└ Buybacks0.00.00.00.0
Net change in cash(8.1)(5.9)(9.9)10.0

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

AGARWALEYE at a glance

  • AGARWALEYE closed at ₹553.4 on 20 Nov 2026, +0.05% on the day, +5.7% over one year, 3.2% below its 52-week high of ₹571.9.
  • Delivery was 51.8% of traded quantity on 20 Nov 2026, the 59th percentile of its own 444 sessions with a reading (20-session average 51.7%, 1-year average 50.7%).
  • Market capitalisation is ₹17,545 crore at a trailing P/E of 101.2 (trailing EPS ₹5.47).
  • Q2 FY27 results (consolidated, filed 5 Nov 2026): revenue ₹655 crore (+31.4% year on year), net profit ₹57 crore (+55.8%); the price moved +0.9% on the first session after.
  • Promoters held 32.33% at 30 Sept 2026, down 0.01 percentage points on the previous filing.
  • Q3 FY27 results are expected between 30 Jan 2027 and 28 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryHospital
ISININE943P01029
SeriesEQ
Listed4 Feb 2025
IPO price402.00 · band Rs.382 to Rs.402
IPO listing4 Feb 2025
NSE market cap · 17 Nov 2026₹17,119 Cr
Free-float market cap (NSE)₹4,189 Cr
Shares outstanding (NSE)31.70Cr
History from4 Feb 2025
Sessions444
Turnover rank#876

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Healthcare Services › Hospital

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.